Lrrk2-G2019S Synergizes With Ageing And Low-Grade Inflammation To Promote Gut And Peripheral Immune Cell Activation That Precede Nigrostriatal Degeneration
Giachino, C.; Tirolo, C.; Caniglia, S.; Serapide, M. F.; L'Episcopo, F.; Bertoli, F.; Giuliano, C.; Mearelli, M.; Jakobi, M.; Schneiderhan-Marra, N.; Deleidi, M.; Marchetti, B.
Show abstract
BackgroundMutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most frequent cause of familial Parkinsons disease (PD). The incomplete penetrance of LRRK2 mutations suggest that additional hits are required for disease onset. We hypothesized that chronic low-grade inflammation interacts with LRRK2 G2019S, the most frequent PD-associated mutation, to activate peripheral and central immune reactions and drive age-dependent neurodegeneration. Methods and ResultsWe exposed wild-type and LRRK2 G2019S mice to a low chronic dose of lipopolysaccharide, and we performed a longitudinal analysis of central and peripheral immune reactions and neurodegeneration. Low-dose inflammation triggered nigrostriatal degeneration, macrophage/monocyte brain infiltration, and astro-/microgliosis. LRRK2 G2019S mice showed an early dysregulation of peripheral cytokines, increased CD4+ T-cell infiltration and -synuclein aggregation in the colon. Interestingly, peripheral immune activation and colonic -synuclein aggregation precede astro-/microgliosis and neurodegeneration. ConclusionsOur study suggests an early role of the peripheral immune system and the gut in LRRK2 PD and provides a novel model to study early therapeutic immune targets and biomarkers.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.